PharmaOnco™ Human Immune Genome Editing Mouse Model, E-hTHPO (CAT#: ITS-1123-HM13)

This mouse model enables irradiation-free hematopoietic stem cell engraftment and improved human erythropoiesis and platelet formation through over-expression of hTHPO.

Human-specific infectious diseases; Antibody-based immune therapy; Human-specific vaccine development; Cell-based adoptiive immunity

NSG (E-hTHPO)